North America Venous Diseases Treatment Market – Industry Trends and Forecast to 2030

Medical Devices
Published Report
Feb 2023
North America
350 Pages
No of Tables: 130
No of Figures: 39

North America Venous Diseases Treatment Market, By Product Type (Sclerotherapy Injection, Ablation Devices, Venous Closure Products, Venous Stents, Medication and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others), Treatment Type (Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation and stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, Venoactive Medication, Vena Cava Filter and Others Therapies), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2030.

North America Venous Diseases Treatment Market Analysis and Insights

Venous disease includes blood clots in the legs, arms, brain, lungs or internal organs such as kidney, spleen, liver, deep vein thrombosis, chronic venous insufficiency, varicose veins, and veins, and ulcers in the veins. Treatment for this disease includes drug therapy, endogenous laser ablation or radiofrequency ablation (RFA), sclerotherapy, and surgery.

Data Bridge Market Research analyzes that the North America venous diseases treatment market is expected to reach the value of USD 4,286.15 million by 2030, at a CAGR of 7.4% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.

Report Metric	Details
Forecast Period	2023 to 2030
Base Year	2022
Historic Years	2021 (Customizable to 2020-1015)
Quantitative Units	Revenue in Million, Pricing in USD
Segments Covered	By Product Type (Sclerotherapy Injection, Ablation Devices, Venous Closure Products, Venous Stents, Medication and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others), Treatment Type (Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation and stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, Venoactive Medication, Vena Cava Filter and Others Therapies), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others)
Countries Covered	U.S., Canada and Mexico.
Market Players Covered	Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips N.V., Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems and Bolitec Laser among others.

North America Venous Diseases Treatment Market Definition

Heart attacks, and strokes are usually acute events, and are primarily caused by a blockage that blocks blood flow to the heart or brain. The most common cause is the build-up of fatty deposits in the lining of the blood vessels that supply the heart or brain. A stroke can be caused by bleeding or blood clots in a blood vessel in the brain.

Technological advancements in vascular stents, increase in demand for minimally invasive procedures, and rise in geriatric population are driving the North America market. Moreover, the companies are expanding their product portfolio to offer the best services for venous diseases treatment. Medical devices such as ablation devices are used in minimally invasive procedures to remove or excise abnormal body tissues for therapeutic purposes. These systems use the heat generated by radio frequency, energy, extreme cold, or a laser to cause small burns. Rise in adoption of robotic technologies for product application expansion, and integration of cutting-edge technologies in ablation devices to improve patient safety, and procedural efficiency are expected to drive the market.

North America Venous Diseases Treatment Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

Rising incidences of venous diseases

Venous diseases are the conditions that damage veins in body. Damaged blood vessel walls prevent the circulatory system from working, causing blood to pool and reflux (backwards) when the muscles relax. This causes abnormally high pressure to build up in the veins. This build-up causes veins to tighten and twist, increased swelling, increased valve incompetence, slow blood flow, and possible blood clots. Finally, this condition can lead to various diseases known as venous diseases.

Due to various risk factors such as ageing, obesity, high blood pressure (hypertension) or family history of venous disease, patients with venous diseases are rising globally and becoming a significant socio-economic issue. Thus the rising number of patients with venous diseases increases the demand for venous diseases treatment which act as a driver in the North America venous diseases treatment market.

Rapid changes in lifestyle leads to obesity resulting in venous diseases

Lifestyle changes such as smoking, unhealthy diet and physical inactivity lead to the development of chronic diseases, especially heart disease, stroke, diabetes, obesity and metabolic syndrome that can eventually result in venous diseases.

Physical activity is essential and many conditions are a direct result of a sedentary lifestyle. Sedentary lifestyle may result in gain weight, tire easily and have unexplained aches and pains that develop chronic condition, including cardiovascular and venous disease, ranging from moderate, severe or even life-threatening.

According to the article of ScienceDirect, venous disease was more clinically severe in the obese limbs than non-obese group. Thus due to increase in adoption of unhealthy lifestyle there is rapid increase in obese population with venous diseases rising. Thus the rapid changes in lifestyle leads to obesity resulting in venous diseases which increases the demand for venous diseases treatment and act as a driver in the North America venous diseases treatment market.

Restraint

Lack of skilled and certified professionals

The requirement of skilled and certified professionals is a big restraint for venous diseases treatment market. The demand for venous disease treatment is increased due to increasing cases of venous diseases in the Europe but the less number of skilled professionals present in the healthcare center is hampering the growth of the market.

Chronic venous disease (CVD) is often overlooked by healthcare professionals because they do not understand the extent and impact of the problem, and the different manifestations of primary and secondary venous disease are not fully recognized. The importance of cardiovascular diseases is related to the number of patients and to the socio-economic effects of its more serious manifestations.

Opportunity

Rising awareness towards venous disorders

Both medicinal procedures and lifestyle changes can be used to treat vein problems. Your veins can benefit from medication, exercise, and compression stockings, but occasionally vein problems necessitate more thorough therapy to restore the health and performance of your veins. The course of treatment is determined by the kind and severity of the venous disease. Patients with vascular disorders have increased dramatically over the past few decades, with diabetes serving as the most flagrant risk factor. Unlike other health problems, vascular disorders and vascular surgery are unknown to approximately 80% of the population. People's attitudes and behaviours about particular illnesses can change significantly as a result of increased health awareness.

There are several awareness programs are conducted by various societies, government institutes and others. These initiatives taken by them will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. For this reason, rising awareness towards venous disorders are expected to act as an opportunity for growing the demand of the North America venous diseases treatment market.

Challenge

High cost associated with venous disease treatment

More than 25 million persons in the United States alone suffer from chronic venous insufficiency (CVI), with more than 6 million having advanced venous illness. The US healthcare system is heavily burdened financially as a result of the high incidence of CVI and rising healthcare costs. Numerous widespread health issues are caused by poor venous circulation. Leg pain, edoema, and heaviness are some of the early signs of chronic venous disease (CVD), and they can be present all day long or become more pronounced in the evening. Patients frequently seek out initial therapy for symptoms that might occur with or without varicose veins, as well as for cosmetic varicose vein removal. The two main risk factors for CVD are advancing age and high body mass.

Post-COVID-19 Impact on North America Venous Diseases Treatment Market

The pandemic has had adverse impacts on the manufacturers as well as users. As varicose veins procedures are non-urgent, the volume of procedures declined drastically. Reduction in the surgeries or procedures for the treatment of varicose veins due to traveling restrictions also impacted the sales of the manufacturers.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pet food flavors and ingredients market.

Recent Developments

In July 2022, Smith+Nephew, the North America medical technology company has launches Clinical Support App to help reduce practice variation in wound care. The WOUND COMPASS Clinical Support App is a comprehensive digital support tool for health care professionals that aids wound assessment and decision-making to help reduce practice variation. This has helped the company to attract the healthcare customers and expand product portfolio
In April 2022, Carl Zeiss Meditec has announced the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider. This has helped the company to expand their business

North America Venous Diseases Treatment Market Scope

North America venous diseases treatment market is segmented into product type, disease type, treatment type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE

ABLATION DEVICES
VENOUS STENTS
VENOUS CLOSURE PRODUCTS
SCLEROTHERAPY INJECTION
MEDICATIONS
OTHERS

On the basis of product type, the North America venous diseases treatment market is segmented into ablation devices, venous stents, venous closure products, sclerotherapy injection, medications, and others

NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE

DEEP VEIN THROMBOSIS (DVT)
CHRONIC VENOUS INSUFFICIENCY (CVI)
PULMONARY EMBOLISM
SUPERFICIAL THROMBOPHLEBITIS
VARICOSE VEINS
OTHERS

On the basis of disease type, the North America venous diseases treatment market is segmented into deep vein thrombosis (DVT), chronic venous insufficiency (CVI), pulmonary embolism, superficial thrombophlebitis, varicose veins, and others

NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE

COMPRESSION THERAPY
VENO ACTIVE MEDICATION
SURGERIES
SCLEROTHERAPY
ANGIOPLASTY OR STENTING
VEIN LIGATION AND STRIPPING
VENA CAVA FILTER
AMBULATORY PHLEBECTOMY
RADIOFREQUENCY ABLATION THERAPY
LASER TREATMENT
OTHERS THERAPIES

On the basis of treatment type, the North America venous diseases treatment market is segmented into compression therapy, veno active medication, surgeries, scelrotherapy, angioplasty or stenting, vein legation, and stripping, vena cava filter, ambulatory phlebectomy, radiofrequency ablation therapy, laser treatment, and other therapies

NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER

HOSPITALS
CLINICS
AMBULATORY SURGICAL CENTERS
OTHERS

On the basis of end user, the North America venous diseases treatment market is segmented into hospitals, clinics, ambulatory surgical centers, and others

NORTH AMERICA VENOUS DISEASES TREATMENTS MARKET, BY DISTRIBUTION CHANNEL

DIRECT TENDER
RETAIL SALES
OTHERS

On the basis of distribution channel, the North America venous diseases treatment market is segmented into direct tender, retail sales, and others

North America Venous Diseases Treatment Market Regional Analysis/Insights

The North America venous diseases treatment market is analyzed and market size information is provided product type, disease type, treatment type, end user, and distribution channel.

The countries covered in this market report U.S., Canada and Mexico.

U.S. is dominating North America due to the presence of key market players in the largest consumer market with high GDP. U.S is expected to grow due to its latest advanced technology and inventions in the venous disease treatment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Venous Diseases Treatment Market Share Analysis

North America venous diseases treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the North America venous diseases treatment market.

Some of the major players operating in the North America venous diseases treatment market are Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips N.V., Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems, Bolitec Laser among others.

SKU-69788

TABLE 1 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 2 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 58 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 59 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 62 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 63 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 65 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 66 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 69 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 72 U.S. VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 73 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 74 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 75 U.S. ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 U.S. THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 U.S. RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 78 U.S. LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 79 U.S. ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 80 U.S. RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 U.S. ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 82 U.S. NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 U.S. CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 85 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 86 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 87 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 89 U.S. VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 90 U.S. VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 91 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 92 CANADA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 93 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 94 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 CANADA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 96 CANADA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 97 CANADA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 CANADA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 99 CANADA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 100 CANADA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 101 CANADA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 102 CANADA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 103 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 104 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 105 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 106 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 107 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 108 CANADA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 109 CANADA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 111 MEXICO VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 112 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 114 MEXICO ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 MEXICO THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 116 MEXICO RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 MEXICO LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 MEXICO ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 119 MEXICO RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 120 MEXICO ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 121 MEXICO NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 MEXICO CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 123 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 124 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 125 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 126 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 127 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 128 MEXICO VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 129 MEXICO VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 130 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

What is the forecasted growth of this market?

The North America Venous Diseases Treatment Market surges a CAGR of 7.4% by 2030

What will be the market value in the future?

The North America Venous Diseases Treatment Market bags $4,286.15 million by 2030

Which market segments are covered in this report?

The North America Venous Diseases Treatment Market report is segmented by product type, disease type, treatment type, end user, and distribution channel.

Which countries data are covered in the report?

The North America Venous Diseases Treatment Market report analyses these countries U.S., Canada, and Mexico.

BROWSE RELATED Press Release

The Rising Incidence of Venous Diseases Drives the Demand for Venous Diseases Treatment Market

Free Sample Report

CHOOSE LICENCE TYPE

Enterprise User 4200.00
Single User 3500.00
DBMR Factbook 2000.00
DBMR Prime 5500.00
DBMR Supreme 7500.00

Buy Now

Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report

Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.